483 GlaxoSmithKline Sep 2018

483 GlaxoSmithKline Sep 2018

Rajiv Srivastava FDA$119.00 - Available Now

FDA investigators audited the GlaxoSmithKline - East Durham, NY, United States facility and issued inspectional observations (via FDA 483) on 11 Sep 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 11 Sep 2018
  • Location: East Durham, United States
  • FEI: 1314819
Add To Cart